Close Menu

NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission this week, Precipio said it had amended and restated an earlier securities purchase agreement with investors. The amendment enables it to issue up to $1.3 million of additional notes with applicable warrants on substantially the same terms and conditions as the notes and warrants granted in connection with the prior securities purchase agreement. Investors can purchase the additional notes and warrants until Dec. 31, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.